Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%, Aiming to Achieve"RMB10 Billion in Profit"

Rhea-AI Summary

Fosun International (OTC:FOSUF) reported total 2025 revenue of RMB173.43 billion and adjusted industrial operation profit of RMB4 billion. Overseas revenue was RMB94.86 billion (54.7%). The Group recorded a RMB23.4 billion book loss from impairments and revaluations.

Fosun invested RMB7.8 billion in technology innovation, secured multiple drug approvals and clinical starts, held RMB61.1 billion cash, and set medium-term targets including restoring annual profit to ~RMB10 billion.

Positive

• Total revenue of RMB173.43 billion in 2025
• Overseas revenue RMB94.86 billion (54.7% of total)
• Adjusted industrial operation profit of RMB4 billion
• Fosun Pharma net profit RMB3.371 billion (+21.69% YoY)
• Tech investment RMB7.8 billion and 16 indications approved

Negative

• Book loss from impairments and revaluations RMB23.4 billion
• Real estate-related impairment ~55% of total impairments
• Total debt to total capital ratio at 57%

Market Context

This announcement highlights Fosun’s 2025 performance, including total revenue of RMB173.43 billion,...

Analysis

This announcement highlights Fosun’s 2025 performance, including total revenue of RMB173.43 billion, growing overseas revenue, and increased investment in innovation. Management simultaneously recognized a sizable RMB23.4 billion non-cash impairment to streamline non-core assets, while emphasizing liquidity with RMB61.1 billion in cash and RMB144.6 billion in undrawn facilities. Investors may watch progress toward the medium-term profit goal and the planned higher dividend payout ratio for 2026.

Key Figures

Total revenue: RMB173.43 billion Adj. industrial operation profit: RMB4 billion Overseas revenue: RMB94.86 billion (54.7%) +5 more

8 metrics

Total revenue RMB173.43 billion 12 months ended 31 Dec 2025

Adj. industrial operation profit RMB4 billion 12 months ended 31 Dec 2025

Overseas revenue RMB94.86 billion (54.7%) 12 months ended 31 Dec 2025; +5.4 ppt YoY share

Annual book loss RMB23.4 billion Non-cash impairments and revaluations in 2025

Total debt to capital 57% As at end of Reporting Period

Cash and term deposits RMB61.1 billion As at end of Reporting Period

Unutilized banking facilities RMB144.6 billion As at end of Reporting Period

Expected 2026 dividends ≥HKD1.5 billion Dividends for 2026 financial year

Historical Context

5 past events · Latest: Dec 21 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Dec 21	ESG awards	Positive	+1.8%	Multiple ESG awards and global healthcare innovation highlights.
Nov 20	ESG recognition	Positive	-5.2%	Named an ESG Leading Enterprise with multiple high ESG ratings.
Nov 06	ESG awards	Positive	-5.2%	Gold Award and Best Sustainability Team for ESG performance.
Nov 06	Innovation showcase	Positive	-5.2%	CIIE participation highlighting oncology and CAR-T innovations.
Oct 30	Consumer initiative	Positive	-5.2%	Launch of International Jewelry Fashion Theme Month in Shanghai.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent positive corporate and ESG news often coincided with negative price reactions, suggesting a pattern of skepticism or selling into good news.

Recent Company History

Over the past six months, Fosun’s news flow has centered on ESG recognition, sustainability leadership, innovation showcases, and consumer initiatives. Awards from Bloomberg Businessweek and The Asset underscored strong ESG credentials, while CIIE participation highlighted healthcare innovation and global reach. Despite this generally positive narrative, several of these announcements saw share price declines of about 5.24%. Today’s earnings update, emphasizing revenue growth and asset streamlining, follows that backdrop of constructive news met with mixed market responses.

Key Terms

non-cash impairment, goodwill, intangible assets, dividend payout ratio, +1 more

5 terms

non-cash impairment financial

"pursuant to the principle of prudence, Fosun made non-cash impairment provisions"

A non-cash impairment is a reduction in a company's asset value that doesn't involve actual money changing hands. It happens when an asset, like equipment or a building, becomes less useful or less valuable than it was before, and the company needs to record that loss in its financial reports. This matters because it shows the true worth of what the company owns and can affect its overall financial health.

goodwill financial

"goodwill and intangible assets of certain non-core business segments"

Goodwill is the extra value a buyer pays for a company above the measurable worth of its buildings, inventory and other tangible items, reflecting things like brand reputation, customer loyalty and expected future profits. Think of paying more for a café because of its famous name and regulars rather than its furniture alone. It matters to investors because changes in goodwill — for example a write-down if expected benefits don’t materialize — can reduce reported earnings and signal that past acquisitions aren’t delivering as hoped.

View in glossary

intangible assets financial

"goodwill and intangible assets of certain non-core business segments"

Non-physical resources a company owns that help it earn money, such as brand names, patents, customer lists, proprietary software, or trade secrets — think of them as a company’s reputation, recipes, or secret formulas that aren’t bricks and mortar. Investors care because these assets can create long-term income, protect market share, and boost the value of a business even if they don’t appear as cash; strong intangible assets can mean higher future profits and lower risk of competitors copying a company’s advantages.

View in glossary

dividend payout ratio financial

"plans to increase its target dividend payout ratio for the 2026 financial year"

The dividend payout ratio is the share of a company’s net profit that is returned to shareholders as cash dividends rather than kept for reinvestment. Investors use it to judge whether dividend payments are likely sustainable and how the company balances rewarding owners with funding growth; a high ratio is like handing most of your paycheck to friends now, while a low ratio is like saving more for future expenses and opportunities.

credit rating financial

"International rating agency S&P has affirmed the outlook for Fosun International's credit rating"

A credit rating is an independent assessment, usually given as a letter grade, of how likely a borrower is to repay its debt on time. It matters to investors because the rating signals how risky a bond or loan is — like a personal credit score for a company or government — and influences the interest the borrower must pay, the price investors will accept, and whether certain funds can hold that security.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HONG KONG, March 30, 2026 /PRNewswire/ -- On 30 March, Fosun International (00656.HK) announced its results for the 12 months ended 31 December 2025. In 2025, Fosun's fundamentals remained solid, core industries such as pharmaceuticals and healthcare and insurance and finance demonstrated a good development trend, and the twin drivers of innovation and globalization delivered strong momentum.

During the Reporting Period, the Group's total revenue reached RMB173.43 billion, and adjusted industrial operation profit amounted to RMB4 billion. The four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group's total revenue. Among them, Fosun Pharma, a core subsidiary in the Health segment, achieved a net profit attributable to shareholders of the parent of RMB3.371 billion, representing a year-on-year increase of 21.69%; Fosun Insurance Portugal, a core subsidiary in the Wealth segment, reported a net profit attributable to owners of the parent of EUR201 million, up 15.8% year on year.

During the Reporting Period, the Group's investment in technology innovation reached RMB7.8 billion, and 16 indications of 7 innovative drugs were approved for marketing in China and overseas markets. In addition, nearly 40 innovative drug clinical trials were approved by regulatory authorities in China, the United States and Europe, while multiple core products entered key clinical phases, laying a solid pipeline foundation for subsequent commercial growth.

During the Reporting Period, the Group's overseas revenue reached RMB94.86 billion, accounting for 54.7% of total revenue, representing a year-on-year increase of 5.4 percentage points. For innovative drugs, total upfront payments from licensing-out and co-development for the year exceeded USD260 million, with total potential milestone payments exceeding USD4 billion. Club Med once again achieved record-high performance, while insurance companies in China and overseas delivered broad-based growth.

Fosun has continued to advance its strategy of "streamlining operations and strengthening the business, focusing on core businesses". During the Reporting Period, pursuant to the principle of prudence, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments, resulting in a book loss of RMB23.4 billion for the year, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%. These provisions do not affect the Company's overall operations and cash flow.

In his letter to shareholders, Guo Guangchang, Chairman of Fosun International, stated: "Some of the projects we invested in years ago are now indeed valued differently under current market conditions from what we expected at the time of investment. Accordingly, the Board has prudently chosen to complete this asset impairment, allowing Fosun to better concentrate its resources and efforts on high-growth core sectors. As the global economy presents opportunities amid fluctuations and China's innovation industry gains momentum, deepening our strategic focus now allows us not only to optimize our asset structure, but also to seize industry opportunities, positioning Fosun as a leaner, healthier, and more sustainable company."

At the same time, Fosun has maintained a healthy financial position, with ample cash reserves, a solid net asset base, and positive net cash inflow from operating activities. As at the end of the Reporting Period, total debt to total capital ratio was 57%; in addition to cash, bank balances and term deposits of RMB61.1 billion, unutilized banking facilities amounted to RMB144.6 billion. A healthy debt ratio and ample funds not only strengthen the Company's risk resilience, but also enhance its capacity to seize opportunities. International rating agency S&P has affirmed the outlook for Fosun International's credit rating as "Stable".

"It is precisely this strong foundation, together with the continued support of our partners, that gives us the confidence and determination to 'repair the roof while the sun is shining' — to shed burdens at this stage and pursue predictable, sustainable growth for the future. We must strengthen our core businesses with greater focus and depth. This is the path for Fosun to move more steadily and go further in the next phase," said Guo Guangchang.

Fosun also announced its medium-term financial targets: to strive to gradually restore annual profit to around RMB10 billion; to target the recovery of RMB60 billion in cash at the Group level, reduce total Group-level debt to below RMB60 billion, and work to achieve an "investment-grade" rating.

In terms of further enhancing shareholder returns, in addition to share purchases by the controlling shareholder and management, as well as the Company's continued share buybacks, Fosun announced that it plans to increase its target dividend payout ratio for the 2026 financial year from the current 20% to 35%, and is committed to further raising the payout ratio over time. Based on the Company's accumulated distributable profits, dividends for the 2026 financial year are expected to be no less than HKD1.5 billion.

"For the future, Fosun will not pursue short-term gains; instead, we will build a solid foundation for enduring growth," said Guo Guangchang.

View original content:https://www.prnewswire.com/news-releases/fosun-international-total-revenue-in-2025-reaches-rmb173-43-billion-with-overseas-revenue-accounting-for-54-7-aiming-to-achievermb10-billion-in-profit-302728815.html

SOURCE Fosun

FAQ

What were Fosun International (FOSUF) key 2025 revenue and profit figures?

Fosun reported RMB173.43 billion revenue and adjusted industrial operation profit of RMB4 billion. According to Fosun International, the Group's overseas revenue reached RMB94.86 billion, representing 54.7% of total revenue.

Why did Fosun International record a RMB23.4 billion book loss in 2025 (FOSUF)?

The book loss mainly resulted from non-cash impairments and revaluations across assets. According to Fosun International, impairments covered certain real estate projects and goodwill in non-core segments, with real estate accounting for about 55% of the total provision.

What medium-term financial targets did Fosun International (FOSUF) announce?

Fosun aims to restore annual profit to around RMB10 billion and cut group-level debt below RMB60 billion. According to Fosun International, the company also targets RMB60 billion cash recovery and an investment-grade rating.

How strong is Fosun International's cash and liquidity position after 2025 results (FOSUF)?

Fosun held RMB61.1 billion in cash, bank balances and term deposits plus RMB144.6 billion unutilized facilities. According to Fosun International, these resources support risk resilience and capacity to pursue opportunities.

What shareholder return changes did Fosun International (FOSUF) propose for 2026 dividends?

Fosun plans to raise its target dividend payout ratio to 35% for the 2026 financial year and expects dividends of at least HKD1.5 billion. According to Fosun International, the company intends to further increase the payout ratio over time.